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Objective: This study aimed to evaluate the incidence and related factors of acute asymptomatic brain
infarcts (aABI) following percutaneous coronary intervention (PCI) in patients with acute myocardial
infarction (AMI) via the right radial approach.
Patients and methods: Two hundred ten consecutive patients with AMI were enrolled. Multiple factors
were compared between patients with (n ¼ 37) and without (n ¼ 138) aABI in 175 patients who un-
derwent PCI.
Results: Of 175 patients with AMI, 37 (21.14%) developed aABI as determined by diffusion-weighted
magnetic resonance imaging (MRI). Incidence of hypertension, proportion of primary PCI (p-PCI),
Killip > 1 on admission, duration of procedure, and the frequency of device insertion into the coronary
artery signiﬁcantly differed between the aABI and non-aABI groups. These signiﬁcant factors were
reevaluated using logistic regression. Proportion of p-PCI, duration of the procedure, and the frequency of
device insertion into the coronary artery were indicated as independent factors related to the incidence
of aABI and others did not.
Conclusion: Cranial MRI imaging following PCI revealed that 21.14% of the patients with AMI had aABI.
The independent factors related to aABI following PCI were p-PCI, duration of the procedure, and the
frequency of device insertion into the coronary artery.
Copyright © 2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
For patients with acute myocardial infarction (AMI), percuta-
neous coronary intervention (PCI) is one of the most effective ways
of maintaining cardiac function and decreasing mortality.
Following equipment and technology development in PCI, the
transradial intervention (TRI) is enlarged, especially in China.have no potential conﬂicts of
/or publication of this article.
f Cardiology, Beijing An Zhen
ct, Beijing 100029, China.
lly to this paper.
tric Emergency & Critical Care MeHowever, cardiac intervention is also a recognized cause of the
serious complication of symptomatic acute ischemic stroke (sAIS),
although the incidence is rare (0.11e0.38%)1e5. Recent advances in
magnetic resonance imaging (MRI), such as diffusion-weighted
imaging (DWI), have detected small and hyperacute lesions of
ischemic stroke, even in patients without clinical symptoms. A
previous study showed that the incidence of acute asymptomatic
brain infarcts (aABI) was in 11% of patients undergoing elective
coronary angiography and in 23% of those having elective PCI (e-
PCI)6. Another study reported that patients with acute coronary
syndrome (ACS) undergoing primary PC I(p-PCI) the incidence of
asymptomatic acute ischemic stroke reached 34.7%7. The incidence
and risk factors of aABI in patients with AMI after PCI through TRI
were rarely reported. The current study assessed the incidence and
related factors of aABI following PCI in patients with AMI.dicine. Published by Elsevier Taiwan LLC. All rights reserved.
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2.1. Study design and study participants
We prospectively studied 210 patients with AMI in two large
hospitals (Beijing Anzhen Hospital, Beijing Daxing Hospital) and
Capital Medical University in Beijing. The inclusion period was
February 2011 to October 2011. Our study included 175 consecutive
patients with PCI through a right radial approach (study group), Of
these patients, 118 were ST-segment elevation myocardial infarction
(STEMI; 76 patients were treated by P-PCI, 24 patients were treated
with thrombolytic therapy and e-PCI, 18 patients were treated with
conservative therapy, and e-PCI) and 57 patients were non-ST
segment elevation myocardial infarction (NSTEMI; 9 patients were
treated with P-PCI, 48 patients were treated with conservative ther-
apyande-PCI). The studyprotocolwasapprovedby theMedicalEthics
Committee of Beijing Anzhen Hospital, Beijing Friendship Hospital,
Beijing Daxing Hospital, and Capital Medical University (Fig. 1).
The control group was deﬁned as 35 consecutive patients with
AMI but without PCI because of any causes that could not complete
coronary angiography. Of these,14 patientswith STEMI treatedwith
thrombolytic therapy refused e-PCI, and 21 patients undergoing
conservative treatment were unable to give informed consent.
All participants provided written informed consent to cranial
MRI (Avanto 1.5T, SIEMENS, Germany), including FLAIR, DWI, T2-
and T1-weighted MRI, and magnetic resonance angiography
(MRA). The control group underwent these procedures within a
mean of 2.0 ± 1.0 days after admission, and the study group un-
derwent these procedures within a mean of 3.0 ± 1.0 days after PCI.
Lesions that generated high intensity with a low apparent diffusion
coefﬁcient value on DWI were considered to be aABI8. Patients in
the study group were assigned to subgroups based on the presence
or absence of aABI. Cranial MRIs were interpreted by two radiolo-
gists who specialize in cerebral imaging and were unaware of the
subgroup sequencing of the patients. We recorded the following
factors: age, body mass index, (BMI) sex, coronary risk factors
(smoking, hyperlipidemia, diabetes mellitus, and hypertension),
50% stenosis in the extracranial carotid arteries on MRA, and
laboratory data.
2.2. Study deﬁnitions and catheter procedure
The diagnosis of AMI is deﬁned as a clinical (or pathologic) event
caused by myocardial ischemia in which there is evidence ofFig. 1. Distribution of the population groups in the study.myocardial injury or necrosis. Criteria are met when there is an
increase and/decrease in cardiac biomarkers, along with supportive
evidence in the form of typical symptoms, suggestive electrocar-
diographic changes, or imaging evidence of new loss of viable
myocardium or new regional wall motion abnormality9,10.
Five cardiologists randomly performed PCI after admission. Af-
ter oral administration of the loading dose of 300 mg of aspirin and
600 mg of clopidogrel, the routine maintaining dose of 100 mg of
aspirin and 75 mg of clopidogrel was administered. The 175
consecutive patients underwent p-PCI and e-PCI through the right
radial artery using a 6 French guiding catheter. Only the cobalt-
chromium alloy, coronary RESOLUTE stent (Medtronic Inc, Min-
neapolis, MN, USA), was implanted according to operator discretion
because of its nonferromagnetic properties. After a sheath was
inserted, 5000 U of unfractionated heparin was administered
and another 5,000 U were added before the initiation of e-PCI and
p-PCI.
2.3. Exclusion criteria
Patients were excluded if they had contraindications to MRI,
such as out-of-hospital cardiac arrest or circulatory support
including intra-aortic counterpulsation or percutaneous cardio-
pulmonary support, history of cerebral ischemia (stroke or tran-
sient ischemic attack within the past 3 months), atrial ﬁbrillations,
valvular heart disease, congestive heart failure with low ejection
fraction, unstable vital parameters, and pregnancy. Because TRI is in
common use, during the period of our study, only four patients
with right femoral approach and two patients with left radial
approach were excluded.
2.4. Statistical analysis
Categorical data were presented as frequencies (percentages);
continuous data were presented as mean value ± standard devia-
tion. Continuous variables were compared between the two groups
using the Mann-Whitney U test. Demographic variables for cate-
gorical data were compared using the chi-square or Fisher exact
test where appropriate. Statistically signiﬁcant factors were
examined using multivariate logistic regression. A p value < 0.05
(two-sided) was considered signiﬁcant. Data were analyzed with
SPSS 21.0 software (IBM, Chicago, IL).
3. Results
Cranial MRI was safely accomplished in all patients. None of the
control patients had aABI, whereas 37 in the study group had aABI
(0% vs. 21.14%, p ¼ 0.006). No one in the study population had sAIS.
All aABI lesions were round in shape and their diameter was 1 cm
or less on DWI. In the study group, the incidence of aABI was 21.14%.
As shown in Table 1, the aABI and non-aABI groups comprised 37
and 138 patients, respectively. The incidence of hypertension and
p-PCI signiﬁcantly differed between the aABI and non-aABI groups,
whereas age, BMI, sex, incidence of hyperlipidemia and diabetes
mellitus, STEMI, and prevalence of extracranial carotid artery ste-
nosis did not. We recorded the laboratory data on admission
(Table 2). There were no signiﬁcant differences in the laboratory
data on admission among patients with aABI and those without
aABI. We used some biochemical indicators to assess the severity of
AMI (Table 3), maximum creatine kinase isoenzyme MB (CK-MB)
mass, cardiac troponin-I (cTnI) and B-type natriuretic peptide
values were not statistically signiﬁcant. The patients with aABI
experienced a higher rate of Killip classiﬁcation (>1) on admission.
Table 4 outlines the results of angiography characters and catheter
procedure. Patients with aABI experienced greater duration of
Table 3
Severity of acute myocardial infarction.
aABI group Non-aABI group p
n ¼ 37 n ¼ 138
Peak of CK-MB mass (ng/mL) 214.8 ± 212.4 237.4 ± 208.1 0.560
Peak of cTnI mass (ng/mL) 31.5 ± 52.1 38.3 ± 58.5 0.522
Peak of BNP mass (pg/mL) 667.8 ± 315.4 645.4 ± 298.2 0.689
MBP on admission (mmHg) 100 ± 26 97 ± 24 0.508
Multivessel disease 15 (40.5%) 46 (33.3%) 0.414
Killip > 1 on admission 13 (35.1%) 26 (18.8%) 0.034
LVEF after admission (%) 54 ± 11 53 ± 8.1 0.605
aABI¼ acute asymptomatic brain infarcts; BNP ¼ B-type natriuretic peptide: cut-off
value of 100 pg/mL; CK-MB, creatine kinase isozyme MB; cTnI ¼ cardiac troponin I;
LVEF ¼ left ventricular ejection fraction; MBP ¼ mean blood pressure.
Table 4
Angiography characteristics and catheter procedure.
aABI group Non-aABI group p
n ¼ 37 n ¼ 138
Culprit lesion
LAD 12 (32.4%) 47 (34.1%) 0.853
LCX 5 (13.5%) 24 (17.4%) 0.573
RCA 20 (54.1%) 67 (48.5%) 0.552
Duration of procedure (min) 69.2 ± 27.3 57.4 ± 23.5 0.010
Contrast volume (mL) 180 ± 55 185 ± 65 0.669
Stents per procedure 1.5 ± 0.8 1.5 ± 1.0 0.999
Postprocedural TIMI-3 ﬂow 34 (91.9%) 130 (94.2%) 0.894
ACT (s) 338 ± 82.5 324 ± 78.3 0.341
Frequency of device insertion 6.2 ± 3.1 5.0 ± 2.5 0.015
Aspiration device 16 (43.2%) 42 (30.4%) 0.142
Catheter experience (n  10 y) 12 (32.4%) 41 (29.7%) 0.749
ACT ¼ activated coagulation time; LAD ¼ left anterior descending coronary artery;
LCX ¼ left circumﬂex coronary artery; RCA ¼ right coronary artery.
Table 1
Characteristics of the study group.
aABI group Non-aABI group p
n ¼ 37 n ¼ 138
Age 58.0 ± 8.4 60.1 ± 10.1 0.247
Male 23 (62.2%) 98 (71%) 0.301
BMI (kg/m2) 25.2 ± 4.7 24.9 ± 4.5 0.722
Smoking 16 (43.2%) 75 (54.3%) 0.230
Hyperlipidemia 17 (45.9%) 78 (56.5%) 0.251
Diabetes mellitus 16 (43.2%) 42 (30.4%) 0.142
Hypertension 19 (51.4%) 46 (33.31%) 0.044
Carotid stenosis 7 (18.9%) 20 (14.5%) 0.508
STEMI 28 (75.7%) 90 (65.2%) 0.228
NSTEMI 9 (24.3%) 48 (34.8%) 0.228
p-PCI 24 (64.9%) 61 (44.2%) 0.026
aABI¼ acute asymptomatic brain infarcts; BMI¼ body mass index; p-PCI ¼ primary
percutaneous coronary intervention; NSTEMI ¼ non-ST segment elevation
myocardial infarction; STEMI ¼ ST-segment elevation myocardial infarction.
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tery. There were no signiﬁcant differences in culprit lesion, contrast
volume, stents per procedure, postprocedural TIMI-3 ﬂow, acti-
vated coagulation time (ACT) after PCI and catheter experience, and
use of aspiration devices. Results of multivariate analysis for sta-
tistical signiﬁcant factors are reported in Table 5. Incidence of hy-
pertension, proportion of p-PCI, Killip > 1 on admission, duration of
procedure, and the frequency of device insertion into the coronary
artery were reevaluated using logistic regression. Proportion of p-
PCI，duration of procedure, and the frequency of device insertion
into the coronary artery were indicated as independent factors
related to the incidence of aABI, and others did not.
There were no differences in location of aABI between the right
hemisphere 17 (46%) and the left hemisphere 20 (54%), anterior
cerebral circulation 22 (59%) and posterior cerebral circulation 15
(41%) in our study.
4. Discussion
Stroke is a potential complication of PCI. Adjunctive antith-
rombotic medications during PCI may increase risk of intracranial
hemorrhagic complications. The incidence of stroke was perhaps
underestimated because of the occurrence of aABI, which could be
easily ignored by clinicians because of the absence of symptoms or
signs. With DW MRI, we analyzed the incidence of aABI after PCI.
We found that patients with AMI without PCI did not have aABI
lesions and the incidence of aABI reached 21.14% in patients with
AMI and PCI through TRI.Table 2
Laboratory data on admission.
aABI group Non-aABI group p
n ¼ 37 n ¼ 138
WBC count (109/L) 12.4 ± 3.7 11.5 ± 3.4 0.162
Total cholesterol (mg/dL) 195.4 ± 54.1 197.4 ± 48.5 0.828
Triglyceride (mg/dL) 175.2 ± 120.6 177.1 ± 130.7 0.936
HDL-cholesterol (mg/dL) 45.1 ± 10.1 43.5 ± 10.2 0.397
LDL-cholesterol (mg/dL) 124.3 ± 39.1 129.7 ± 40.2 0.467
Hs-CRP (mg/dL) 4.5 ± 3.6 3.8 ± 2.4 0.264
Blood sugar (mg/dL) 206 ± 78.5 192 ± 72.1 0.305
D-Dimer 1.5 ± 1.2 1.2 ± 0.7 0.142
CK-MB mass (ng/mL) 13.4 ± 28.9 23.1 ± 55.4 0.306
BNP (pg/mL) 215.2 ± 104.5 203.1 ± 101.3 0.522
Serum creatinine 1.0 ± 0.9 1.1 ± 1.0 0.582
aABI ¼ acute asymptomatic brain infarcts; BNP ¼ B-type natriuretic peptide: cut-off
value of 100 pg/mL; CK-MB, creatine kinase isozyme MB; HDL ¼ high-density
lipoprotein; Hs-CRP ¼ high-sensitivity C-reactive protein; LDL ¼ low-density lipo-
protein; WBC ¼ white blood cell.Whether the approach to the coronary artery could affect the
incidence of aABI during catheter procedures could not be fully
proved. Murai et al7 analyzed differences in the incidence of aABI
after either the femoral artery or upper limb approach to the cor-
onary artery during catheter procedures, and there were no dif-
ferences (p ¼ 0.883). Hamon et al11 found a high incidence of silent
cerebral infarct after cardiac catheterization of patients with aortic
stenosis The risk of silent cerebral infarct did not differ signiﬁcantly
between the femoral and radial groups (incidence of 11.7% vs. 17.5%;
odds ratio 0.85; 95% conﬁdence interval, 0.62e1.16; p ¼ 0.31)11. The
inﬂuence of route of access on aABI has not been deﬁnitively
established and additional research is needed.
Our research and previous studies6,7 showed that without
catheter manipulation no patients had aABI. It was suggested that
aABI occurred because of manipulation of catheters. The size and
shape of the lesion on DWI suggested that embolic stroke was the
cause of aABI. An embolic source in patients undergoing PCI was
not clear. There was no statistical difference in extracranial carotid
artery stenosis between the aABI and non-aABI groups. Moreover,
there was no catheter manipulation in the carotid arteries during
cardiac catheterization, and there was strong indication that thatTable 5
Multivariate analysis for statistically signiﬁcant factors.
OR (95%CI) p
Hypertension 2.11 (1.01e4.41) 0.108
p-PCI 2.33 (1.16e4.98) 0.035
Killip > 1 on admission 2.31 (1.01e5.04) 0.465
Duration of procedure 2.34 (1.23e5.28) 0.041
Frequency of device insertion 2.06 (1.24e4.92) 0.018
CI ¼ conﬁdence interval; OR ¼ odds ratio; p-PCI ¼ primary percutaneous coronary
intervention.
Acute Asymptomatic Brain Infarcts 73carotid artery embolismwas not an emboli source. All data strongly
indicated that catheter manipulations were important sources. We
found that the independent factors related to aABI following PCI
were p-PCI, duration of procedure, and the frequency of device
insertion into the coronary artery. However, other studies showed
different results. Murai et al7 found that PCI time was not an in-
dependent factor related to asymptomatic acute ischemic stroke.
Most reports currently indicate that procedural time was an inde-
pendent predictor of the occurrence of cerebral infarction6,12,13.
Murai et al7 reported that the independent factors related to
asymptomatic acute ischemic stroke following p-PCI were right
coronary artery (RCA) as the culprit vessel and the frequency of
device insertion into the coronary artery. We also found that the
frequency of device insertion into the coronary artery was an in-
dependent predictor of the occurrence of aABI, but we did not ﬁnd
that RCA as the culprit vessel was an independent predictor. These
results suggested that aABI mainly occurs either while manipu-
lating the catheter or device at the bottom of the ascending aorta,
which scratches the aortic wall14, when pulling a thrombus through
the coronary artery using devices, or when pushing air bubbles out
of the guiding catheters while using devices or contrast me-
dium15,16. However, currently there is no evidence to deﬁne the
source of emboli.
We found that the incidence of aABI in patients who underwent
p-PCI and those who underwent e-PCI was signiﬁcantly different
(28.2% vs.14.4%, p¼ 0.026) and p-PCI was an independent predictor
of the occurrence of aABI. The strong association with p-PCI in
multivariate analysis was noteworthy and has not been reported
previously. The mechanism is not clear. Some possible reasons
include embolism because of high coagulability, and distal emboli
of fragile plaque from the coronary ostial lesion, in particular when
thrombus aspiration devices are used7. However, as in previous
studies, we also could not ﬁnd a statistical difference between the
aABI and non-aABI groups in the frequency of using thrombus
aspiration devices because patient numbers were small. Further
investigations are required to explain the mechanism.
There were no differences in location of aABI between right
hemisphere and left hemisphere, anterior cerebral circulation, and
posterior cerebral circulation in our study. We can see that all le-
sions were either located in noneloquent brain areas or were too
small to be clinically apparent. The long-term effect of such lesions
has not been investigated, but there are indications that they may
lead to impaired cognitive function17e19. aABI has been associated
with dementia or depression. Fujikawa et al identiﬁed silent brain
ischemia onMRI in 51.4% of patients with presenile-onset presenile
depression, in 65.9% of those with presenile-onset senile depres-
sion, and in 93.7% of those with senile-onset depression20. In
addition, Vermeer et al concluded from a mean 3.6-year follow-up
of 1015 participants that the presence of silent brain ischemia at
baselinemore than doubled the risk of dementia21. The relationship
between aABI and dementia or depression is not clear and should
be investigated in the future.
5. Study limitations
The current study has certain limitations; there were relatively
few patients and the number of those with aABI was small. Another
limitation is that cranial MRI was not performed before PCI for
ethical reasons. Hence, the results of the current study should be
interpreted with caution.6. Conclusion
Cranial MRI following PCI revealed that 21.14% of the patients
with AMI had aABI. The independent factors related to aABI
following PCI were p-PCI, duration of procedure, and the frequency
of device insertion into the coronary artery.
Funding/Support
There were no external funding sources for this study.
References
1. Segal AZ, Abernethy WB, Palacios IF, et al. Stroke as a complication of cardiac
catheterization: risk factors and clinical features. Neurology. 2001;56:975e977.
2. Fuchs S, Stabile E, Kinnaird TD, et al. Stroke complicating percutaneous coro-
nary interventions incidence, predictors, and prognostic implications. Circula-
tion. 2002;106:86e91.
3. Leker RR, Pollak A, Abramsky O, et al. Abundance of left hemispheric embolic
strokes complicating coronary angiography and PTCA. J Neurol Neurosurg Psy-
chiatry. 1999;66:116e117.
4. Dukkipati S, O'Neill WW, Harjai KJ, et al. Characteristics of cerebrovascular
accidents after percutaneous coronary interventions. J Am Coll Cardiol. 2004;43:
1161e1167.
5. Aggarwal A, Dai D, Rumsfeld JS, et al. Incidence and predictors of stroke
associated with percutaneous coronary intervention. Am J Cardiol. 2009;104:
349e353.
6. BüsingKA, Schulte-Sasse C, Flüchter S, et al. Cerebral infarction: incidence and risk
factors after diagnostic and interventional cardiac catheterizationdprospective
evaluation at diffusion-weighted MR imaging 1. Radiology. 2005;35:177e183.
7. MuraiM,HazuiH, SugieA, et al. Asymptomatic acute ischemic stroke afterprimary
percutaneous coronary intervention in patients with acute coronary syndrome
might be caused mainly by manipulating catheters or devices in the ascending
aorta, regardless of the approach to the coronary artery. Circ J. 2008;72:51e55.
8. MoseleyME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging
of acute stroke: correlation with T2-weighted and magnetic susceptibility-
enhanced MR imaging in cats. Am J Neuroradiol. 1990;11:423e429.
9. Antman E, Bassand JP, Klein W, et al. Myocardial infarction redeﬁnedda
consensus document of The Joint European Society of Cardiology/American
College of Cardiology committee for the redeﬁnition of myocardial infarction.
J Am Coll Cardiol. 2000;6:959e969.
10. Bonaca MP, Wiviott SD, Braunwald E, et al. American College of Cardiology/
American Heart Association/European Society of Cardiology/World Heart
Federation Universal Deﬁnition of Myocardial Infarction Classiﬁcation System
and the Risk of Cardiovascular Death Observations From the TRITON-TIMI 38
Trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing
Platelet Inhibition With PrasugreleThrombolysis in Myocardial Infarction 38).
Circulation. 2012;125:577e583.
11. Hamon M, Lipiecki J, Carrie D, et al. Silent cerebral infarcts after cardiac cath-
eterization: A randomized comparison of radial and femoral approaches. Am
Heart J. 2012;164:449e454.
12. Bendszus M, Koltzenburg M, Burger R, et al. Silent embolism in diagnostic
cerebral angiography and neurointerventional procedures: a prospective
study. Lancet. 1999;354:1594e1597.
13. Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral em-
bolism after retrograde catheterisation of the aortic valve in valvular stenosis: a
prospective, randomised study. Lancet. 2003;361:1241e1246.
14. Galbreath C, Salgado ED, Furlan AJ, et al. Central nervous system complications
of percutaneous transluminal coronary angioplasty. Stroke. 1986;17:616e619.
15. Wijman CAC, Kase CS, Jacobs AK, et al. Cerebral air embolism as a cause of
stroke during cardiac catherization. Neurology. 1998;51:318e319.
16. Stygall J, Kong R, Walker JM, et al. Cerebral microembolism detected by
transcranial Doppler during cardiac procedures. Stroke. 2000;31:2508e2510.
17. Fukutake T, Akada K, Ito S, et al. Severe personality changes after unilateral left
paramedian thalamic infarct. Eur Neurol. 2002;47:156e160.
18. Desmond DW. Cognition and white matter lesions. Cerebrovasc Dis. 2002;13:
53e57.
19. Van Zandvoort MJE, De Haan EHF, Kappelle LJ. Chronic cognitive disturbances
after a single supratentorial lacunar infarct. Cogn Behav Neurology. 2001;14:
98e102.
20. Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in
patients with major depression. Stroke. 1993;24:1631e1634.
21. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of
dementia and cognitive decline. N Engl J Med. 2003;348:1215e1222.
